Filed: 2026-04-17 AccNo: 0001443194-26-000004 Size: 7 KB
NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
4 - INTEGRATED BIOPHARMA INC
Filed:
2026-04-17
AccNo:
0001345281-26-000004
Size:
7 KB
发布时间04/17 15:21 UTC
首次发现04/17 15:25 UTC
热度106.3
重要度74
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 509 字符
Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001345281-26-000004
Filing Date: 2026-04-17
Accepted: 2026-04-17 11:21:53
Documents: 1
Period of Report: 2026-04-15
INTEGRATED BIOPHARMA INC ( Issuer ) CIK : 0001016504 (see all company filings) EIN. : 222407475 | State of Incorp.: DE | Fiscal Year End: 0630 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | PRIMARY DOCUMENT | primary_doc.html | 4
1 | PRIMARY DOCUMENT | primary_doc.xml | 4
同簇相关文章
从当前文章回到同一事件簇里的其他来源或补充材料。
2 篇
Filed: 2026-04-17 AccNo: 0001102948-26-000002 Size: 7 KB